George Ng, a partner at PENG Life Science Ventures and veteran biotech executive, has been a member of Calidi’s Board of Directors since October 2019. His significant experience includes serving in various executive-level positions for multiple publicly-traded and private global biotechnology and pharmaceutical firms—including BioDelivery Sciences International, Inc., Spectrum Pharmaceuticals, Inc., Sorrento Therapeutics, Inc., and Alpharma, Inc., now part of Pfizer, Inc. Throughout these roles, Ng has contributed his expertise to the launches and commercialization efforts of multiple pharmaceutical drug products, co-founding and leading one pain medication company from preclinical to clinical research, through NDA submission, FDA approval, commercialization, and the subsequent sale of the business—raising over $140 million in non-dilutive commercialization funding in the process. Early in his career, Ng worked as a partner in private practice at two law firms named to the Am Law 200 Report. He holds a JD degree from the University of Notre Dame School of Law, as well as a BAS double degree in Biochemistry and Economics from the University of California, Davis.
Board Member — Appointed October 2019